Recent economic developments in Europe have impacted the state of specialty pharmacy. Here is an overview of the fluid situation and a comparison with the United States specialty market.
Dimitris Dogramatzis, RPh, PhD
Advertisement
Articles by Dimitris Dogramatzis, RPh, PhD
The exploration of the freedom to operate in the specialty biopharmaceutical market, which requires specific steps and processes.
Advertisement
Latest Updated Articles
- The Importance of Freedom to Operate for Specialty Biopharmaceuticals
February 22nd 2012
- Specialty Pharmacy in the European Union
December 18th 2012
Advertisement
Advertisement
Trending on Pharmacy Times
1
Men Face Higher Odds of Later-Stage Diagnosis Across 20 Cancer Types
2
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
3
FDA Accepts NDA for AD109 to Treat of Adults With Obstructive Sleep Apnea
4
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
5